We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Huntington Ingalls Industries
HII
$13B
| $21M | 0.03% |
61,895
+43,676
| +240% | +$13.6M |
|
|
LMRI
652
Lumexa Imaging Holdings
LMRI
$1.13B
| $21M | 0.03% |
+1,134,572
| New | +$20.5M |
|
653
CALL
Qualcomm
QCOM
$170B
| $21M | 0.03% |
122,600
-12,300
| -9% | -$2.11M |
|
654
CenterPoint Energy
CNP
$26.4B
| $20.9M | 0.03% |
545,747
+381,926
| +233% | +$14.9M |
|
655
Raymond James Financial
RJF
$34.5B
| $20.9M | 0.03% |
130,205
-158,378
| -55% | -$25.6M |
|
656
CALL
Black Hills Corp
BKH
$5.62B
| $20.8M | 0.03% |
+300,000
| New | +$20.2M |
|
657
Annaly Capital Management
NLY
$17.3B
| $20.8M | 0.03% |
930,294
-43,760
| -4% | -$953K |
|
658
American Electric Power
AEP
$66.9B
| $20.8M | 0.03% |
180,128
+50,856
| +39% | +$6.01M |
|
659
Louisiana-Pacific
LPX
$5.2B
| $20.7M | 0.03% |
256,565
+55,617
| +28% | +$4.7M |
|
660
MoonLake Immunotherapeutics
MLTX
$1.47B
| $20.7M | 0.03% |
1,571,071
-128,164
| -8% | -$1.51M |
|
661
CALL
Nutanix
NTNX
$17.4B
| $20.7M | 0.03% |
400,000
-250,000
| -38% | -$15.3M |
|
662
PUT
Carnival Corporation Ltd
CCL
$38B
| $20.7M | 0.03% |
676,700
-79,600
| -11% | -$2.22M |
|
663
Liberty Energy
LBRT
$3.45B
| $20.7M | 0.03% |
1,119,309
-1,634,048
| -59% | -$27.3M |
|
664
IDEAYA Biosciences
IDYA
$3.54B
| $20.6M | 0.03% |
596,483
+216,172
| +57% | +$6.89M |
|
665
KLA
KLAC
$252B
| $20.6M | 0.03% |
169,680
+167,150
| +6,607% | +$19.6M |
|
666
CALL
Ionis Pharmaceuticals
IONS
$9.46B
| $20.6M | 0.03% |
260,600
+200
| +0.1% | +$15.1K |
|
667
CALL
Walt Disney
DIS
$178B
| $20.5M | 0.03% |
180,600
+33,100
| +22% | +$3.65M |
|
668
Ericsson
ERIC
$32.7B
| $20.5M | 0.03% |
2,125,063
+2,111,786
| +15,906% | +$20M |
|
669
Ares Capital
ARCC
$14.3B
| $20.4M | 0.03% |
+1,008,351
| New | +$20.3M |
|
670
CALL
Caterpillar
CAT
$385B
| $20.3M | 0.03% |
35,500
+19,700
| +125% | +$10.9M |
|
671
PUT
Salesforce
CRM
$162B
| $20.3M | 0.03% |
76,600
-11,200
| -13% | -$2.78M |
|
672
PUT
Morgan Stanley
MS
$338B
| $20.3M | 0.03% |
114,200
-134,300
| -54% | -$22.4M |
|
|
HI
673
DELISTED
Hillenbrand
HI
| $20.3M | 0.03% |
638,810
+600,361
| +1,561% | +$18.5M |
|
|
QXO
674
QXO Inc
QXO
$16.6B
| $20.2M | 0.03% |
1,046,348
+221,945
| +27% | +$4.25M |
|
675
Hasbro
HAS
$13.3B
| $20.1M | 0.03% |
244,973
+141,962
| +138% | +$11.1M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.